摘要
骨髓间充质干细胞是多潜能祖细胞,能够分化为成骨细胞、软骨细胞、脂肪细胞。为阐明潜在的机制及广泛的临床应用,在体内外的实验研究里,这些细胞被刺激表现出显著的免疫调节性能。本篇我们描述了骨髓间充质干细胞对免疫细胞的影响及其在动物模型和自身免疫性疾病的临床试验中的应用。应该指出的是,虽然临床应用的数量正在稳步增加,为避免过高的错误的期望,应谨慎解释其结果。主要在临床应用的争议是骨髓间充质干细胞的异质性及其治疗后随访的不可预知的行为。然而,越来越多的对外源性细胞和宿主组织之间的相互作用的认识以及部分令人鼓舞的临床观察表明,在不久的将来我们在坚实的基础上将进一步扩展骨髓间充质干细胞的治疗应用。
关键词: 动物模型,自身免疫性疾病,临床试验,骨髓间充质干细胞/基质细胞
图形摘要
Current Drug Targets
Title:The Use of Mesenchymal Stem Cells for the Treatment of Autoimmunity: From Animals Models to Human Disease
Volume: 17 Issue: 2
Author(s): Alessandra Fierabracci, Andrea Del Fattore, Marta Muraca, Domenico Vittorio Delfino and Maurizio Muraca
Affiliation:
关键词: 动物模型,自身免疫性疾病,临床试验,骨髓间充质干细胞/基质细胞
摘要: Mesenchymal stem cells are multipotent progenitors able to differentiate into osteoblasts, chondrocytes and adipocytes. These cells also exhibit remarkable immune regulatory properties, which stimulated both in vitro and in vivo experimental studies to unravel the underlying mechanisms as well as extensive clinical applications. Here, we describe the effects of MSCs on immune cells and their application in animal models as well as in clinical trials of autoimmune diseases. It should be pointed out that, while the number of clinical applications is increasing steadily, results should be interpreted with caution, in order to avoid rising false expectations. Major issues conditioning clinical application are the heterogeneity of MSCs and their unpredictable behavior following therapeutic administration. However, increasing knowledge on the interaction between exogenous cell and host tissue, as well as some encouraging clinical observations suggest that the therapeutic applications of MSCs will be further expanded on firmer grounds in the near future.
Export Options
About this article
Cite this article as:
Alessandra Fierabracci, Andrea Del Fattore, Marta Muraca, Domenico Vittorio Delfino and Maurizio Muraca , The Use of Mesenchymal Stem Cells for the Treatment of Autoimmunity: From Animals Models to Human Disease, Current Drug Targets 2016; 17 (2) . https://dx.doi.org/10.2174/1389450116666150722140633
DOI https://dx.doi.org/10.2174/1389450116666150722140633 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gene Therapy Strategies Towards Immune Tolerance to Treat the Autoimmune Diseases
Current Gene Therapy Vitamin D: Evolutionary, Physiological and Health Perspectives
Current Drug Targets B-Cell Based Gene Therapy for Inducing Tolerance
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Possible Role of DNA Methylation in the Induction of Systemic Lupus Erythematosus
Current Rheumatology Reviews Interleukin-25: Key Regulator of Inflammatory and Autoimmune Diseases
Current Pharmaceutical Design BX471: A CCR1 Antagonist with Anti-Inflammatory Activity in Man
Mini-Reviews in Medicinal Chemistry Hepatitis C Viruss Immune Evasion Strategies
Current Immunology Reviews (Discontinued) Role of Inflammation in the Development of Colorectal Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Systemic Immunomodulation of Autoimmune Disease Using MHC-Derived Recombinant TCR Ligands
Current Drug Targets - Inflammation & Allergy Small Molecular Inhibitors for the Treatment of Rheumatoid Arthritis: Progress so Far
Mini-Reviews in Medicinal Chemistry CCL17/Thymus and Activation-Related Chemokine: A biomarker for Churg-Strauss Syndrome?
Current Biomarkers (Discontinued) A Quantitative Structure-Activity Relationship Study on Some Series of Potassium Channel Blockers
Medicinal Chemistry Regulation of Ocular Immune Responses by Corneal Epithelium
Current Immunology Reviews (Discontinued) Transglutaminases as Targets for Pharmacological Inhibition
Mini-Reviews in Medicinal Chemistry Mesenchymal Stem Cell as a Potential Therapeutic for Inflammatory Bowel Disease- Myth or Reality?
Current Stem Cell Research & Therapy MICA Gene and Relevance to Immune Responses in Organ Transplants and Inflammatory, Tumoral and Autoimmune Diseases
Current Immunology Reviews (Discontinued) Role of Glucocorticoids in Breast Cancer
Current Pharmaceutical Design Therapeutic Utility and Medicinal Chemistry of Cathepsin C Inhibitors
Current Topics in Medicinal Chemistry Gluten-dependent Intestinal Autoimmune Response
Current Pharmaceutical Design Diabetes Mellitus: A Potential Target for Stem Cell Therapy
Current Stem Cell Research & Therapy